Carlson Capital’s Alexion Pharmaceuticals Inc ALXN Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2021
Q3 | – | Sell |
-679,150
| Closed | -$125M | – | 212 |
|
2021
Q2 | $125M | Buy |
679,150
+65,759
| +11% | +$12.1M | 6.02% | 3 |
|
2021
Q1 | $93.8M | Buy |
613,391
+128,391
| +26% | +$19.6M | 3.49% | 5 |
|
2020
Q4 | $75.8M | Buy |
+485,000
| New | +$75.8M | 2.7% | 8 |
|
2017
Q3 | – | Sell |
-114,697
| Closed | -$14M | – | 270 |
|
2017
Q2 | $14M | Sell |
114,697
-259,803
| -69% | -$31.6M | 0.2% | 159 |
|
2017
Q1 | $45.4M | Buy |
374,500
+269,883
| +258% | +$32.7M | 0.58% | 53 |
|
2016
Q4 | $12.8M | Buy |
+104,617
| New | +$12.8M | 0.15% | 163 |
|
2015
Q3 | – | Sell |
-71,484
| Closed | -$12.9M | – | 348 |
|
2015
Q2 | $12.9M | Buy |
+71,484
| New | +$12.9M | 0.14% | 189 |
|